Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bradyrhizobium japonicum Cobyric acid synthase (cobQ) CSB-YP804680BVW
CSB-EP804680BVW
CSB-BP804680BVW
CSB-MP804680BVW
CSB-EP804680BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Error-prone DNA polymerase (dnaE2), partial CSB-YP804681BVW
CSB-EP804681BVW
CSB-BP804681BVW
CSB-MP804681BVW
CSB-EP804681BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Uncharacterized RNA methyltransferase bll2648 (bll2648) CSB-YP804682BVW
CSB-EP804682BVW
CSB-BP804682BVW
CSB-MP804682BVW
CSB-EP804682BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP804683BVW
CSB-EP804683BVW
CSB-BP804683BVW
CSB-MP804683BVW
CSB-EP804683BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum UPF0176 protein bll2403 (bll2403) CSB-YP804684BVW
CSB-EP804684BVW
CSB-BP804684BVW
CSB-MP804684BVW
CSB-EP804684BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Putative cysteine protease yopT-like blr2140 (blr2140) CSB-YP804685BVW
CSB-EP804685BVW
CSB-BP804685BVW
CSB-MP804685BVW
CSB-EP804685BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Probable transcriptional regulatory protein blr1534 (blr1534) CSB-YP804686BVW
CSB-EP804686BVW
CSB-BP804686BVW
CSB-MP804686BVW
CSB-EP804686BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Urease accessory protein UreG (ureG) CSB-YP804687BVW
CSB-EP804687BVW
CSB-BP804687BVW
CSB-MP804687BVW
CSB-EP804687BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP804688BVW
CSB-EP804688BVW
CSB-BP804688BVW
CSB-MP804688BVW
CSB-EP804688BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Homoserine kinase (thrB) CSB-YP804689BVW
CSB-EP804689BVW
CSB-BP804689BVW
CSB-MP804689BVW
CSB-EP804689BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Amino acid--[acyl-carrier-protein] ligase 1 (bll0957) CSB-YP804691BVW
CSB-EP804691BVW
CSB-BP804691BVW
CSB-MP804691BVW
CSB-EP804691BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum 30S ribosomal protein S20 (rpsT) CSB-YP804692BVW
CSB-EP804692BVW
CSB-BP804692BVW
CSB-MP804692BVW
CSB-EP804692BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Tryptophan--tRNA ligase (trpS) CSB-YP804693BVW
CSB-EP804693BVW
CSB-BP804693BVW
CSB-MP804693BVW
CSB-EP804693BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Ribosome-binding factor A (rbfA) CSB-YP804694BVW
CSB-EP804694BVW
CSB-BP804694BVW
CSB-MP804694BVW
CSB-EP804694BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP804695BVW
CSB-EP804695BVW
CSB-BP804695BVW
CSB-MP804695BVW
CSB-EP804695BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Cytidylate kinase (cmk) CSB-YP804696BVW
CSB-EP804696BVW
CSB-BP804696BVW
CSB-MP804696BVW
CSB-EP804696BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP804697BVW
CSB-EP804697BVW
CSB-BP804697BVW
CSB-MP804697BVW
CSB-EP804697BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP804698BVW
CSB-EP804698BVW
CSB-BP804698BVW
CSB-MP804698BVW
CSB-EP804698BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum UPF0434 protein bsr0601 (bsr0601) CSB-YP804699BVW
CSB-EP804699BVW
CSB-BP804699BVW
CSB-MP804699BVW
CSB-EP804699BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum Putative pterin-4-alpha-carbinolamine dehydratase (bll0532) CSB-YP804700BVW
CSB-EP804700BVW
CSB-BP804700BVW
CSB-MP804700BVW
CSB-EP804700BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>